Growing community of inventors

Morgantown, WV, United States of America

Knox Van Dyke

Average Co-Inventor Count = 1.17

ph-index = 5

The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.

Forward Citations = 80

Knox Van DykeMeir Sacks (2 patents)Knox Van DykeVal Vallyathan (1 patent)Knox Van DykeVincent Castranova (1 patent)Knox Van DykeNar S Dalal (1 patent)Knox Van DykeKnox Van Dyke (12 patents)Meir SacksMeir Sacks (4 patents)Val VallyathanVal Vallyathan (1 patent)Vincent CastranovaVincent Castranova (1 patent)Nar S DalalNar S Dalal (1 patent)
..
Inventor’s number of patents
..
Strength of working relationships

Company Filing History:

1. Cancer Biologics of America, Inc. (5 from 5 patents)

2. Other (3 from 832,812 patents)

3. Hiv Diagnostics, Inc. (3 from 3 patents)

4. The United States of America As Represented by the Secretary of (1 from 2,202 patents)


12 patents:

1. 7128930 - Compositions and methods for treating sexual dysfunction

2. 6962927 - Method for potentiating primary drugs in treating multidrug resistant disease

3. 6911454 - Method for potentiating primary drugs in treating multidrug resistant disease

4. 6544726 - KVD solution for transplantable organs

5. 6528519 - Use of tetrandrine and its derivatives to treat malaria

6. 6514955 - Multi-faceted method to repress reproduction of latent viruses in humans and animals

7. 6124315 - Method for potentiating primary drugs in treating multidrug resistant

8. 5846961 - Multi-faceted method to repress reproduction of latent viruses in humans

9. 5686436 - Multi-faceted method to repress reproduction of latent viruses in humans

10. 5332747 - Method for potentiating primary drugs in treating multidrug resistant

11. 5096733 - Prevention of the acute cytotoxicity associated with silica containing

12. 5025020 - Use of tetrandrine and its derivatives to treat malaria

Please report any incorrect information to support@idiyas.com
idiyas.com
as of
12/20/2025
Loading…